Wireless power transfer via strongly coupled magnetic resonances

Using self-resonant coils in a strongly coupled regime, we experimentally demonstrated efficient nonradiative power transfer over distances up to 8 times the radius of the coils. We were able to transfer 60 watts with approximately 40% efficiency over distances in excess of 2 meters. We present a quantitative model describing the power transfer, which matches the experimental results to within 5%. We discuss the practical applicability of this system and suggest directions for further study.     

Enzyme-coenzyme complexes of pyridine nucleotide-linked dehydrogenases

Enzyme-reduced coenzyme binary complexes produce previously unreported shifts in the spectrum of the free coenzyme. These shifts give rise to difference spectra which resemble a general environmental change for reduced diphosphopyridine nucleotide (DPNH) in the glutamic dehydrogenase-DPNH complex, and indicate a more specific enzyme-coenzyme interaction for yeast alcohol dehydrogenase-DPNH, isocitrate dehydrogenase-TPNH, and lactic dehydrogenase-DPNH complexes.     

Molecular Growth Requirements of Single Mammalian Cells

The molecular nutritional requirements exhibited by mammalian cells can vary with the following conditions: whether the cells are plated singly or in massive inoculum; whether a clonal strain or a mixture of different genotypes is employed; whether the macromolecular fraction of serum used as a supplement was previously exposed to prolonged dialysis or other procedures which may release bound micromolecules. In addition, the nature of the medium in which the cells were previously grown, the time permitted for incubation of the cells in the test medium, and the presence of substances or conditions which may specifically introduce the need for certain molecules to preserve balance can strongly influence nutritional requirements. This great versatility may reflect the ability of the mammalian cell to assume different metabolic states characteristic of specific types of differentiation. Under certain conditions, growth of single HeLa cells of the S3 clonal strain requires the presence of cholesterol at a level of 0.5 to 1 microgram per milliliter.     

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor

Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clinical immunosuppression. We report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants. CP-690,550 treatment was not associated with hypertension, hyperlipidemia, or lymphoproliferative disease. On the basis of these preclinical results, we believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clinical settings.     

Instruction-level parallel processing

The performance of microprocessors has increased steadily over the past 20 years at a rate of about 50% per year. This is the cumulative result of architectural improvements as well as increases in circuit speed. Moreover, this improvement has been obtained in a transparent fashion, that is, without requiring programmers to rethink their algorithms and programs, thereby enabling the tremendous proliferation of computers that we see today. To continue this performance growth, microprocessor designers have incorporated instruction-level parallelism (ILP) into new designs. ILP utilizes the parallel execution ofthe lowest level computer operations-adds, multiplies, loads, and so on-to increase performance transparently. The use of ILP promises to make possible, within the next few years, microprocessors whose performance is many times that of a CRAY-IS. This article provides an overview of ILP, with an emphasis on ILP architectures-superscalar, VLIW, and dataflow processors-and the compiler techniques necessary to make ILP work well.     

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

Amyloid deposition in senile plaques and the cerebral vasculature is a marker of Alzheimer's disease. Whether amyloid itself contributes to the neurodegenerative process or is simply a by-product of that process is unknown. Pheochromocytoma (PC12) and fibroblast (NIH 3T3) cell lines were transfected with portions of the gene for the human amyloid precursor protein. Stable PC12 cell transfectants expressing a specific amyloid-containing fragment of the precursor protein gradually degenerated when induced to differentiate into neuronal cells with nerve growth factor. Conditioned medium from these cells was toxic to neurons in primary hippocampal cultures, and the toxic agent could be removed by immunoabsorption with an antibody directed against the amyloid polypeptide. Thus, a peptide derived from the amyloid precursor may be neurotoxic.     

Tissue plasminogen activator reduces neurological damage after cerebral embolism

Intravenous administration of tissue plasminogen activator immediately after the injection of numerous small blood clots into the carotid circulation in rabbit embolic stroke model animals caused a significant reduction in neurological damage. In vitro studies indicate that tissue plasminogen activator produced substantial lysis of clots at concentrations comparable to those expected in vivo, suggesting that this may be the mechanism of action of this drug. Drug-induced hemorrhages were not demonstrable. Tissue plasminogen activator may be of value for the immediate treatment of embolic stroke.